American Association for Cancer Research
Browse
10780432ccr152879-sup-158784_2_supp_3389566_c3kcvw.xlsx (20.06 kB)

Supplementary Table 5 from Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy

Download (20.06 kB)
dataset
posted on 2023-03-31, 19:29 authored by Etienne Becht, Aurélien de Reyniès, Nicolas A. Giraldo, Camilla Pilati, Bénédicte Buttard, Laetitia Lacroix, Janick Selves, Catherine Sautès-Fridman, Pierre Laurent-Puig, Wolf Herman Fridman

Consensus Molecular Subgroup-level statistics on each MCP-counter abundance estimates

Funding

Institut National de la Santé et de la Recherche Médicale

University Pierre et Marie Curie

Institut National Du Cancer

CARPEM, Labex Immuno-Oncology

Fondation ARC pour la Recherche sur le Cancer

Cancérop⊚le Ile-de-France

Universidad de los Andes

Colciencias

B3MI doctorate

PPATH doctorate

History

ARTICLE ABSTRACT

Purpose: The tumor microenvironment is formed by many distinct and interacting cell populations, and its composition may predict patients' prognosis and response to therapies. Colorectal cancer is a heterogeneous disease in which immune classifications and four consensus molecular subgroups (CMS) have been described. Our aim was to integrate the composition of the tumor microenvironment with the consensus molecular classification of colorectal cancer.Experimental Design: We retrospectively analyzed the composition and the functional orientation of the immune, fibroblastic, and angiogenic microenvironment of 1,388 colorectal cancer tumors from three independent cohorts using transcriptomics. We validated our findings using immunohistochemistry.Results: We report that colorectal cancer molecular subgroups and microenvironmental signatures are highly correlated. Out of the four molecular subgroups, two highly express immune-specific genes. The good-prognosis microsatellite instable–enriched subgroup (CMS1) is characterized by overexpression of genes specific to cytotoxic lymphocytes. In contrast, the poor-prognosis mesenchymal subgroup (CMS4) expresses markers of lymphocytes and of cells of monocytic origin. The mesenchymal subgroup also displays an angiogenic, inflammatory, and immunosuppressive signature, a coordinated pattern that we also found in breast (n = 254), ovarian (n = 97), lung (n = 80), and kidney (n = 143) cancers. Pathologic examination revealed that the mesenchymal subtype is characterized by a high density of fibroblasts that likely produce the chemokines and cytokines that favor tumor-associated inflammation and support angiogenesis, resulting in a poor prognosis. In contrast, the canonical (CMS2) and metabolic (CMS3) subtypes with intermediate prognosis exhibit low immune and inflammatory signatures.Conclusions: The distinct immune orientations of the colorectal cancer molecular subtypes pave the way for tailored immunotherapies. Clin Cancer Res; 22(16); 4057–66. ©2016 AACR.

Usage metrics

    Clinical Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC